COVID-19 and Cancer Patients
NCT04393974 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3820
Last updated 2026-02-17
Summary
Routinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.
Conditions
- Cancer
- Sars-CoV2
Sponsors & Collaborators
-
Imperial College London
lead OTHER
Principal Investigators
-
David J Pinato, Prof. · Clinical Professor of Experimental Cancer Therapeutics
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2024-04-01
- Completion
- 2024-04-01
Countries
- Belgium
- France
- Germany
- Italy
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Impact of COVID-19 on Lung Cancer Patients
NCT04538456 ·Status: COMPLETED
-
Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients
NCT05009030 ·Status: COMPLETED
-
Prevalence of COPD in Our Lung Cancer Population, Compared to Controls
NCT02603627 ·Status: UNKNOWN
-
Transcriptomal and Molecular Characterization of Tumor Associated Monocytes/Macrophages in Human Cancers
NCT00979277 ·Status: UNKNOWN
-
Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer
NCT01192256 ·Status: COMPLETED
-
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 ·Status: COMPLETED ·Phase: PHASE3
-
Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response
NCT03988192 ·Status: TERMINATED ·Phase: NA
-
Hypermetabolism in the Elderly Lung Cancer Patient
NCT03141957 ·Status: COMPLETED
-
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection
NCT04407143 ·Status: COMPLETED
-
OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients
NCT04548960 ·Status: UNKNOWN ·Phase: NA
-
Breath Analysis to Diagnose Lung Cancer
NCT03250390 ·Status: COMPLETED ·Phase: NA
-
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
NCT06557967 ·Status: COMPLETED
-
Cognition and Patients With Lung Cancer
NCT07160751 ·Status: NOT_YET_RECRUITING
-
Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)
NCT04721444 ·Status: COMPLETED
-
Assay Development for Cancer Biomarkers
NCT02874729 ·Status: UNKNOWN
-
Health Outcomes and Costs (HOC) in Lung Cancer (LC)
NCT02363101 ·Status: UNKNOWN
-
LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)
NCT04344002 ·Status: COMPLETED
-
Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients
NCT05988970 ·Status: COMPLETED ·Phase: NA
-
COPD Care Pathway Among Patients With Cancer
NCT05984680 ·Status: COMPLETED
-
Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma
NCT03938012 ·Status: UNKNOWN
-
The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer
NCT06000358 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy
NCT02821949 ·Status: UNKNOWN
-
Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection
NCT03803137 ·Status: UNKNOWN ·Phase: NA
-
Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology
NCT01596452 ·Status: UNKNOWN
-
Safe Return to Regular Clinical Operation After COVID-19 Pandemic
NCT04377802 ·Status: UNKNOWN ·Phase: NA